Rockefeller Capital Management
HCAT icon

Rockefeller Capital Management’s Health Catalyst HCAT Stock Holding History

Rockefeller Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11
Closed -$26 – 4777
2025
Q4 		$26 Hold
11
– – ﹤0.01% 4652
2025
Q3 		$31 Buy
+11
New +$38 ﹤0.01% 4402
2023
Q1 		– Sell
-4,689
Closed -$49K – 2801
2022
Q4 		$49K Buy
4,689
+83
+2% +$801 ﹤0.01% 2392
2022
Q3 		$44K Buy
4,606
+4,576
+15,253% +$60.6K ﹤0.01% 2407
2022
Q2 		$0 Sell
30
-89
-75% -$1.52K ﹤0.01% 4223
2022
Q1 		$3K Buy
119
+89
+297% +$2.52K ﹤0.01% 3502
2021
Q4 		$1K Sell
30
-11
-27% -$501 ﹤0.01% 3643
2021
Q3 		$2K Hold
41
– – ﹤0.01% 3436
2021
Q2 		$2K Buy
41
+12
+41% +$639 ﹤0.01% 3245
2021
Q1 		$1K Sell
29
-43
-60% -$2.08K ﹤0.01% 3175
2020
Q4 		$3K Buy
72
+39
+118% +$1.44K ﹤0.01% 2555
2020
Q3 		$1K Buy
+33
New +$1.12K ﹤0.01% 2480

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rockefeller Capital Management's HCAT Position: Q1 2026 in Review

Rockefeller Capital Management sold out of Health Catalyst (HCAT) in Q1 2026, closing a stake of 11 shares — an estimated $26 sold.

Rockefeller Capital Management first reported a position in HCAT in Q3 2020 and held it in 12 quarters. The position peaked at $49K in Q4 2022. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Rockefeller Capital Management reported no remaining Health Catalyst position as of Q1 2026 after selling out during the quarter.
  • Rockefeller Capital Management sold 11 Health Catalyst shares in Q1 2026, an estimated $26.
  • Rockefeller Capital Management first reported a position in Health Catalyst in Q3 2020 and held it in 12 quarters.
  • Rockefeller Capital Management's Health Catalyst position peaked at $49K in Q4 2022.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.